MTT Cytotoxicity Study

MTT Cytotoxicity testing is a colorimetric assay used to evaluate the biocompatibility of medical device materials by measuring their impact on cell viability. The test assesses whether substances leached from a device are toxic to cultured cells. It relies on the reduction of MTT—a yellow tetrazolium salt—by mitochondrial enzymes in living cells, forming purple formazan crystals. The intensity of the color correlates with the number of viable cells. This assay is widely used during material selection, preclinical testing, and regulatory submission to ensure that devices do not induce harmful cellular effects.

Why This Testing is Performed

MTT testing is conducted to:

• Identify cytotoxic effects of materials used in medical devices.
• Ensure that leachables from the device do not impair cell metabolism or proliferation.
• Support regulatory compliance and product safety during development and premarket approval.
• Replace or reduce animal testing by providing a reliable in vitro alternative.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Extract Preparation: The device is incubated in a suitable extraction medium under controlled conditions.
2. Cell Exposure: Cultured mammalian cells are exposed to the extract.
3. MTT Addition: MTT reagent is added to the culture; viable cells reduce it to formazan.
4. Color Development: After incubation, the formazan is solubilized, and absorbance is measured spectrophotometrically.
5. Data Interpretation: Cell viability below 70% compared to reagent control indicates cytotoxic potential.

Standards, Guidance, and Regulations

• ISO 10993-5: The primary standard for in vitro cytotoxicity testing, including MTT assay protocols and acceptance criteria.
• ISO 10993-12: Provides guidance on sample preparation and extraction methods.
• FDA Guidance on Biocompatibility: Recommends cytotoxicity testing as part of a risk-based biological evaluation.